Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sensus Healthcare (SRTS) Interest & Investment Income (2016 - 2024)

Sensus Healthcare has reported Interest & Investment Income over the past 9 years, most recently at $279000.0 for Q3 2024.

  • For Q3 2024, Interest & Investment Income rose 0.72% year-over-year to $279000.0; the TTM value through Sep 2024 reached $979000.0, down 2.1%, while the annual FY2022 figure was $382000.0, 19000.0% up from the prior year.
  • Interest & Investment Income for Q3 2024 was $279000.0 at Sensus Healthcare, up from $209000.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $279000.0 in Q3 2024 and troughed at $1000.0 in Q4 2021.
  • A 5-year average of $136714.3 and a median of $164000.0 in 2022 define the central range for Interest & Investment Income.
  • Biggest five-year swings in Interest & Investment Income: plummeted 97.32% in 2020 and later soared 24200.0% in 2023.
  • Year by year, Interest & Investment Income stood at $2000.0 in 2020, then plummeted by 50.0% to $1000.0 in 2021, then skyrocketed by 23400.0% to $235000.0 in 2022, then grew by 17.87% to $277000.0 in 2023, then rose by 0.72% to $279000.0 in 2024.
  • Business Quant data shows Interest & Investment Income for SRTS at $279000.0 in Q3 2024, $209000.0 in Q2 2024, and $214000.0 in Q1 2024.